The following is a summary of "Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and ...

Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...

For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

People who regularly engage in significant amounts of exercise, as endurance athletes do, may develop enlarged hearts. While ...

People with a complex heart, kidney and metabolic-related condition who got better quality sleep were less likely to have an ...

Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...

Further reductions in HCC and hepatic decompensation risks were seen in association with exposure to lipophilic statins and duration of statin ... patients with serial FIB-4 data with intermediate ...

If you own an Apple Watch, you know how many helpful features are packed into such a small, wrist-based device. You can ...

Wojciech Jurczak, MD, PhD, ​​discusses nemtabrutinib and its development for the treatment of follicular lymphoma.